H.R. 941 · 117th Congress

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021

Stage
Signed by the president
Sponsor
Doris Matsui
Introduced
2021-02-08
Latest action
2021-05-26 · Signed by President.

Action history

  1. 2021-05-26Signed by President.
  2. 2021-05-26Became Public Law No: 117-15.
  3. 2021-05-20Presented to President.
  4. 2021-05-18Message on Senate action sent to the House.
  5. 2021-05-17Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
  6. 2021-05-17Passed Senate without amendment by Voice Vote.
  7. 2021-04-19Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  8. 2021-04-15Motion to reconsider laid on the table Agreed to without objection.
  9. 2021-04-15On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109).
  10. 2021-04-15Considered as unfinished business.
  11. 2021-04-14At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  12. 2021-04-14DEBATE - The House proceeded with forty minutes of debate on H.R. 941.
  13. 2021-04-14Considered under suspension of the rules.
  14. 2021-04-14Mr. Pallone moved to suspend the rules and pass the bill.
  15. 2021-02-09Referred to the Subcommittee on Health.
  16. 2021-02-08Introduced in House
  17. 2021-02-08Referred to the House Committee on Energy and Commerce.